Curis
CRIS
#11142
Rank
NZ$4.23 M
Marketcap
NZ$1.75
Share price
-8.26%
Change (1 day)
-39.79%
Change (1 year)

EPS for Curis (CRIS)

EPS in 2026 (TTM): NZ-$40.19

According to Curis's latest financial reports the company's current EPS (TTM) is NZ-$41.58. In 2025 the company made an earnings per share (EPS) of NZ-$41.58 an increase over its 2024 EPS that were of NZ-$245.63.

EPS history for Curis from 2011 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ-$40.19-3.35%
2025NZ-$41.58-83.07%
2024NZ-$245.63-22.15%
2023NZ-$315.51-26.17%
2022NZ-$427.3222.3%
2021NZ-$349.40-25.37%
2020NZ-$468.20-30.93%
2019NZ-$677.84-2.02%
2018NZ-$691.81
2016NZ-$1,572-10%
2015NZ-$1,747138.1%
2014NZ-$733.7440%
2013NZ-$524.10-25%
2012NZ-$698.8066.67%
2011NZ-$419.28

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
NZ$2.29-105.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$6.22-114.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
NZ-$0.63-98.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
NZ$5.47-113.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
NZ-$7.44-82.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
NZ-$8.80-78.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
NZ-$0.30-99.29%๐Ÿ‡บ๐Ÿ‡ธ USA